Giglio, R.V.; Papanas, N.; Rizvi, A.A.; Ciaccio, M.; Patti, A.M.; Ilias, I.; Pantea Stoian, A.; Sahebkar, A.; Janez, A.; Rizzo, M.
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina 2022, 58, 1475.
https://doi.org/10.3390/medicina58101475
AMA Style
Giglio RV, Papanas N, Rizvi AA, Ciaccio M, Patti AM, Ilias I, Pantea Stoian A, Sahebkar A, Janez A, Rizzo M.
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina. 2022; 58(10):1475.
https://doi.org/10.3390/medicina58101475
Chicago/Turabian Style
Giglio, Rosaria Vincenza, Nikolaos Papanas, Ali Abbas Rizvi, Marcello Ciaccio, Angelo Maria Patti, Ioannis Ilias, Anca Pantea Stoian, Amirhossein Sahebkar, Andrej Janez, and Manfredi Rizzo.
2022. "An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes" Medicina 58, no. 10: 1475.
https://doi.org/10.3390/medicina58101475
APA Style
Giglio, R. V., Papanas, N., Rizvi, A. A., Ciaccio, M., Patti, A. M., Ilias, I., Pantea Stoian, A., Sahebkar, A., Janez, A., & Rizzo, M.
(2022). An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina, 58(10), 1475.
https://doi.org/10.3390/medicina58101475